Moleculin declares new antiviral drug candidates demonstrate in vitro activity against HIV. Also shows activity in Zika and Dengue Fever ... Oct 06
The pharma co. anticipates it will take at least twelve months of development work to assess clinical potential for these new molecules... Sep 29
Sterling Signs Deal to contract manufacture COVID-19 Drug Candidate for Moleculin ... Jul 28
-Advertisements-